ASSOCIATION BETWEEN LOSS OF Dp140 AND COGNITIVE
IMPAIRMENT IN DUCHENNE AND BECKER DYSTROPHIES
Chamova T1,*, Guergueltcheva V1, Raycheva M1, Todorov T2,3,
Genova J2, Bichev S4, Bojinova V5, Mitev V3, Tournev I1,6, Todorova A2,3
*Corresponding Author: Teodora Chamova, M.D., Ph.D., Clinic of Neurology, University Hospital “Alexandrovska”,
1 Georgi Sofiiski str., Sofia 1431, Bulgaria; Tel.: +359-889802252; Fax: +359-2-9526787; E-mail: teodoratch@abv.bg
page: 21
|
|
REFERENCES
1. Griggs RC, Bushby K. Continued need for caution
in the diagnosis of Duchenne muscular dystrophy.
Neurology. 2005; 64(10): 1498-1499.
2. Barnea E, Zuk D, Simantov R, Nudel U, Yaffe
D. Specificity of expression of the muscle and
brain dystrophin gene promoters in muscle and
brain cells. Neuron. 1990; 5(6): 881-888.
3. Boyce FM, Beggs AH, Feener C, Kunkel LM.
Dys-trophin is transcribed in brain from a distant
upstream promoter. Proc Natl Acad Sci USA.
1991; 88(4): 1276-1280.
4. Gorecki DC, Monaco AP, Derry JMJ, Walker
AP, Barnard AE, Barnard PJ. Expression of four
alternative dystrophin transcripts in brain regions
regulated by different promoters. Hum Mol Genet.
1992; 1(7): 505-510.
5. Hugnot JP, Gilgenkrantz H, Vincent N, Chafey P,
Morris GE, Monaco AP, et al. Distal transcript of
the dystrophin gene initiated from an alternative
first exon and encoding a 75-kDa protein widely
distributed in non muscle tissues. Proc Natl Acad
Sci USA. 1992; 89(16): 7506-7510.
6. Lederfein D, Levy Z, Augier N, Mornet D, Morris
G, Fuchs O, et al. A 71-kilodalton protein is a major
product of the Duchenne muscular dystrophy
gene in brain and other nonmuscle tissues. Proc
Natl Acad Sci USA. 1992; 89(12): 5346-5350.
7. Rapaport D, Passos-Bueno MR, Takata RI, Campiotto
S, Eggers S, Vainzof M, et al. A deletion
including the brain promoter of the Duchenne
muscular dystrophy gene is not associated with
mental retardation. Neuromusc Disord. 1992;
2(2): 117-120.
8. Byers TJ, Lidov HGW, Kunkel LM. An alternative
dystrophin transcript specific to peripheral
nerve. Nat Genet. 1993; 4(1): 77-81. 9. Pereira CC, Kiyomoto BH, Cardoso R,
Oliveira AS. Duchenne muscular dystrophy,
α-dystroglycan immuno-expression in skeletal
muscle and cognitive performance. Arq Neuropsiquiatr.
2005; 63(4): 984-989.
10. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi
M, Comi GP, et al. N. Loss of Dp140 dystrophin
isoform and intellectual impairment in Duchenne
dystrophy Neurology. 2000; 55(4): 559-564.
11. Billard C, Gillet P, Signoret JL, Uicaut E, Bertrand
P, Fardeau M, et al. Cognitive functions
in Duchenne muscular dystrophy: A reappraisal
and comparison with spinal muscular atrophy.
Neuromusc Disord. 1992; 2(5-6): 371-378.
12. Moizard M, Billard C, Toutain A, Berret F, Marmin
N, Moraine C. Are Dp71 and Dp140 brain
dystrophin isoforms related to cognitive impairment
in Duchenne muscular dystrophy? Am J
Med Genet. 1998; 80(1): 32-41.
13. Cotton S, Voudouris NJ, Greenwood KM. Intel-ligence
and Duchenne muscular dystrophy: full-scale,
verbal, and performance intelligence quotients. Dev
Med Child Neurol. 2001; 43(7): 497-501.
14. Schneider SC, Tan G. Attention-deficit hyperactivity
disorder. In pursuit of diagnostic accuracy.
Postgrad Med. 1997; 101(4): 231-232.
15. Bardoni A, Sironi M, Felisari G, Comi GP, Bresolin
N. Absence of brain Dp140 isoform and
cognitive impairment in Becker muscular dystrophy.
Lancet 1999; 353(9156): 897-898.
16. Young HK, Barton BA, Waisbren S, Dale LP,
Ryan MM, Webster RI, et al. Cognitive and psychological
profile of males with Becker muscular
dystrophy. J Child Neurol. 2008; 23(2): 155-162.
17. D’Angelo MG, Bresolin N. Cognitive impairment
in neuromuscular disorders. Muscle Nerve.
2006; 34(1): 16-33.
18. Bardoni A, Felisari G, Sironi M, Comi G, Lai M,
Robotti M, et al. Loss of Dp140 regulatory sequences
is associated with cognitive impairment
in dystrophinopathies. Neuromusc Dis. 2000;
10(3): 194-199.
19. Lidov HGW, Selg S, Kunkel LM. Dp140: a novel
140 KDa CNS transcript from the dystrophin
locus. Hum Mol Genet. 1995; 4(3): 329-335.
20. Taylor PJ, Betts GA, Maroulis S, Gilissen C,
Pedersen RL, Mowat DR, et al. Dystrophin gene
mutation location and the risk of cognitive impairment
in Duchenne muscular dystrophy. PLoS
ONE 2010; 5(1): 1-9.
21. Bhat S, Schmidt K, Ladd S, Kim K, Schwartz
C, Simensen RJ, et al. Disruption of DMD and
deletion of ACSL4 causing developmental delay,
hypotonia, and multiple congenital anomalies.
Cytogenet Genome Res. 2006; 112(1-2): 170-175.
22. Moizard M, Toutain A, Fournier D, Berret F,
Raynaud M, Billard C, et al. Severe cognitive
impairment in DMD: obvious clinical indication
for Dp71 isoform point mutation screening. Eur
J Hum Genet. 2000; 8(7): 552-556.
23. Anderson JL, Head SI, Rae C, Morely JW. Brain
function in Duchenne muscular dystrophy. Brain.
2002; 125(Pt 1): 4-13.
24. Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt
F, Conrad B, et al. Neuropsychological impairments
and the impact of dystrophin mutations
on general cognitive functioning of patients with
Duchenne muscular dystrophy. J Clin Neurosci.
2011; 18(1): 90-95.
25. D’Angelo MG, Lorusso, Civati F, Comi GP, Magri
F, Del Bo R, et al. Neurocognitive profiles in
Duchenne muscular dystrophy and gene mutation
site. Pediatr Neurol. 2011; 45(5): 292-299.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
